Most Read Articles
Tristan Manalac, 2 days ago
Patients who recover from, and then subsequently test positive for, the novel coronavirus disease (COVID-19) show no clinical, laboratory, and treatment distinctions from patients with a more typical disease course, according to a recent study.
03 Oct 2020
Children and young adults with brain abscess have a higher risk of mortality for up to 5 years, according to a study, which notes new-onset epilepsy in 28 percent of survivors and its persisting risk several years following infection.
Pearl Toh, 16 Oct 2020
More than half of the patients who recovered from COVID-19 experienced persistent fatigue regardless of their disease severity, shows a study presented at ECCVID 2020.

Invasive Mould Disease in ICU

05 Oct 2020
Some fungal diseases go undiagnosed which leads to serious illness and death. Increased awareness about fungal diseases is one of the most important ways we can improve early recognition and provide life-saving treatment. IMD poses a significant challenge in the intensive care unit (ICU) affecting both neutropenic and non-neutropenic patients. Invasive aspergillosis (IA) is the most common type of IMD that is usually underestimated and one of the most frequently missed diagnosis found post-mortem. Another type of IMD found in the ICU is mucormycosis which also has a significant mortality rate despite the advances in the diagnosis and treatment. To learn more about Fungal Disease Awareness, please view the video and click this link: https://ph-mims.com/fdaw2020.
Editor's Recommendations
Most Read Articles
Tristan Manalac, 2 days ago
Patients who recover from, and then subsequently test positive for, the novel coronavirus disease (COVID-19) show no clinical, laboratory, and treatment distinctions from patients with a more typical disease course, according to a recent study.
03 Oct 2020
Children and young adults with brain abscess have a higher risk of mortality for up to 5 years, according to a study, which notes new-onset epilepsy in 28 percent of survivors and its persisting risk several years following infection.
Pearl Toh, 16 Oct 2020
More than half of the patients who recovered from COVID-19 experienced persistent fatigue regardless of their disease severity, shows a study presented at ECCVID 2020.